SBTX
NEUTRALSkinBioTherapeutics Announces Director Shareholding Change
The healthcare company has announced a change in director shareholding.
SkinBioTherapeutics
15.85GBX
3.93%
Market Cap
41.02M
Volume
2.69M
225% of avg
P/E Ratio
6003.79
EPS (TTM)
0
Beta
0.64
Day Range
15.00p - 15.98p
52 Week Range
12.00p15.85p27.50p
15.85p
Upcoming Events
SBTX
NEUTRALSkinBioTherapeutics Provides Business Update Ahead of AGM
The life science company has provided a business update ahead of its upcoming AGM, reconfirming market guidance for the current financial year.
SBTX
NEUTRALSkinBioTherapeutics Announces Director Shareholding Change
The healthcare company has announced a change in director shareholding.
SBTX
NEUTRALSkinBioTherapeutics Provides Annual Report and AGM Notice
The life science company has posted its annual report and notice of AGM to shareholders.
SBTX
NEUTRALSkinBioTherapeutics Reports Strong Revenue Growth but Faces Market Headwinds
The life science company reported a 284% revenue increase and reduced losses, buoyed by strategic acquisitions and product launches. However, it faces market headwinds and economic uncertainty while still operating at a loss.
SBTX
NEUTRALSkinBioTherapeutics Announces Director Shareholding Change
The healthcare company has announced a change in director shareholding.
SBTX
NEUTRALSkinBioTherapeutics Announces Director Shareholding Change
The healthcare company has announced a change in director shareholding.
SBTX
NEUTRALSkinBioTherapeutics Announces Director Shareholding Change
The healthcare company has announced a change in director shareholding.
SBTX
NEUTRALSkinBioTherapeutics Announces Directorate Change
The life science company announces the departure of its Chief Operating Officer on personal grounds.
SBTX
NEUTRALSkinBioTherapeutics Announces Holding Change
The healthcare company has announced a change in its major shareholding, with Optibiotix Health plc reducing its stake in the business.